2.19 (-0.04%)
As of Aug 05, 2022
Source:
We are an advanced, late clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted antibacterial products that address high unmet medical needs to treat serious infections caused by multidrug-resistant pathogens.
| Country | United States |
| Headquarters | waltham, massachusetts |
| Phone Number | (781) 810-0120 |
| Industry | manufacturing |
| CEO | Manoussos Perros |
| Website | entasistx.com |